celecoxib has been researched along with Substance Withdrawal Syndrome in 1 studies
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haney, M | 1 |
| Bedi, G | 1 |
| Cooper, ZD | 1 |
| Herrmann, ES | 1 |
| Reed, SC | 1 |
| Foltin, RW | 1 |
| Kingsley, PJ | 1 |
| Marnett, LJ | 1 |
| Patel, S | 1 |
1 trial available for celecoxib and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers.
Topics: Cannabinoid Receptor Agonists; Cannabis; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Dronabinol | 2022 |